On 5 February 2025 at 07:30 CET, we will publish our financial results for the full year of 2024, including the following:
- Company announcement
- Download financial workbook
- Investor presentation
- Annual Report 2024
- Go to the conference call webcast
Thes above documents and links will first be available on
5 February 2025.
We announced our financial results for the three first months of 2024.
Download financial workbook (xlsx)
Investor presentation (iPaper)
We announced our financial results for the six first months of 2024.
Download financial workbook (xlsx)
Investor presentation (iPaper)
We announced our financial results for the first 9 months of 2024.
Download financial workbook (xlsx)
Investor presentation (ipaper)
Our CEO, Lars Fruergaard Jørgensen, presented at the Annual J.P. Morgan Healthcare Conference in San Francisco, USA on 09 January.
Our Capital Markets Day took place on the 7th of March.
Novo Nordisk Executive Management and other members of senior management provided a full review of our strategy, operations and financial targets.
We held our Annual General Meeting on 21 March 2024 at 14:00 CET.
Watch recordings and download documents from our latest Annual General Meeting.
Annual Report
Download
Annual report 2023 (pdf) | 2023 i tilbageblik (iPaper)
Quarterly results
Q4
Novo Nordisk A/S announced financial results for the full year
of 2023:
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q3
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q2
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Other events
Annual General Meeting
23 March 2023
Annual General Meeting (webcast)
Generalforsamling (webcast)
See previous AGM documentation
R&D investor call in relation to ADA 2023
26 June 2023
Presentation (Webcast)
Download presentation (pdf)
American Heart Association (AHA) conference
11-12
November 2023
Annual Report
Download Annual Report 2022 (pdf) | 2022 i tilbageblik (iPaper)
Quarterly results
Q4
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q3
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q2
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Other Events
Capital Markets Day
03 March 2022
Watch the presentations and get the slides from the Novo Nordisk Capital Markets Day
Annual General Meeting
24 March 2022
Annual General Meeting (webcast)
See previous Annual General Meeting documentation
Investor event (ADA 82nd Scientific Sessions)
5 June 2022
Novo Nordisk investor and analyst event at ADA 2022 (Webcast)
Download the ADA investor presentation (pdf)
Annual Report
Download Annual Report 2021 (pdf) | 2021 i tilbageblik (iPaper)
Quarterly results
Q4
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q3
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q2
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Other events
Conference call on supply situation for Wegovy®
20 December 2021
R&D investor call
28 June 2021
Approval of Wegovy™ in the US
7 June 2021
International Operations call
21 May 2021
Annual General Meeting
25 March 2021
Annual Report
Download Annual Report 2020 (pdf)
Quarterly results
Q4
Download company announcement (pdf)
Download financial workbook (xlsx)
Watch Novo Nordisk CEO reflect on the full year results 2021 (video)
Investor presentation (iPaper)
Earnings conference call (webcast)
London
earnings conference call (webcast)
Q3
Download company Announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q2
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Oher events
Decision to enter phase 3 development in Alzheimer’s disease and
GLP-1 R&D strategy update
16 December 2020
ESG conference call
30 November 2020
Download the ESG presentation (pdf)
Novo Nordisk raises sales and operating profit outlook for 2020
9 October 2020
R&D investor presentation
19 June 2020
Annual General Meeting
26 March 2020
Annual Report
Download
Annual report 2019 (PDF) | Årsskrift 2019 (PDF)
Financial results
Q4
Q3
Q2
Q1
Other events
Annual General meeting (webcast)
Approval of Rybelsus in the USA (webcast)
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}